Skip to content
  • News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

NSclc Treatment

  • Overview of Lung Cancer
    August 29, 2025

    Overview of Lung Cancer

    Dr. C H Weaver MD
  • Tagrisso – First Precision Medicine Approved for Treatment of Early Stage NSCLC
    August 21, 2025

    Tagrisso – First Precision Medicine Approved for Treatment of Early Stage NSCLC

    Dr. C H Weaver MD
  • NRG 1 Fusion Genes Can be Targeted with the Zenocutuzumab Bispecific Antibody
    December 5, 2024

    NRG 1 Fusion Genes Can be Targeted with the Zenocutuzumab Bispecific Antibody

    Dr. C H Weaver MD
  • CancerConnect – November is Lung Cancer Awareness Month
    November 1, 2023

    CancerConnect – November is Lung Cancer Awareness Month

    Dr. C H Weaver MD
  • Perioperative and Neoadjuvant Immunotherapy in Early Stage Lung Cancer
    October 27, 2023

    Perioperative and Neoadjuvant Immunotherapy in Early Stage Lung Cancer

    Dr. C H Weaver MD
  • Retevmo (selpercatinib) Treatment of Lung and Other “RET Fusion” Cancers
    October 24, 2023

    Retevmo (selpercatinib) Treatment of Lung and Other “RET Fusion” Cancers

    Dr. C H Weaver MD
  • Imfinzi in Non-Small Cell Lung Cancer
    October 17, 2023

    Imfinzi in Non-Small Cell Lung Cancer

    Dr. C H Weaver MD
  • Braftovi – Mektovi for Non-small cell lung cancer with a BRAF V600E Mutation
    October 12, 2023

    Braftovi – Mektovi for Non-small cell lung cancer with a BRAF V600E Mutation

    Dr. C H Weaver MD
  • Anti-TROP-2 Antibody Drug Conjugate Trodelvy Evaluated in Non-Small Cell Lung Cancer
    September 14, 2023

    Anti-TROP-2 Antibody Drug Conjugate Trodelvy Evaluated in Non-Small Cell Lung Cancer

    Dr. C H Weaver MD
  • Datopotamab (Dato-Dxd) Treatment for Non-Small Cell Lung Cancer
    September 5, 2023

    Datopotamab (Dato-Dxd) Treatment for Non-Small Cell Lung Cancer

    Dr. C H Weaver MD
  • Diagnosed with Lung Cancer? 10 Must Read Tips to be an Empowered Patient
    March 29, 2022

    Diagnosed with Lung Cancer? 10 Must Read Tips to be an Empowered Patient

    Dr. C H Weaver MD
  • Lung Cancer Surgery
    March 11, 2022

    Lung Cancer Surgery

    Dr. C H Weaver MD
1 2 3
Next Page
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy

Loading Comments...